Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 13, 2007
Stem Cells Vol. 25 No. 12 December 2007, pp. 3204 -3214
doi:10.1634/stemcells.2007-0284; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0284v1
25/12/3204    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, X.
Right arrow Articles by Cao, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, X.
Right arrow Articles by Cao, Q.

TISSUE-SPECIFIC STEM CELLS

Bone Morphogenetic Protein Signaling and Olig1/2 Interact to Regulate the Differentiation and Maturation of Adult Oligodendrocyte Precursor Cells

Xiaoxin Chenga,b, Yaping Wanga,b,d, Qian Hea,b, Mengsheng Qiua,c, Scott R. Whittemorea,b,c, Qilin Caoa,b

aKentucky Spinal Cord Injury Research Center and
Departments of bNeurological Surgery and
cAnatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky, USA;
dDepartment of Anesthesiology, Second Xian-Ya Hospital of South Central University, Changsha, Hunan, People's Republic of China

Key Words. Adult oligodendrocyte precursor cell • Spinal cord • Bone morphogenetic protein • Transcription factor • Differentiation • Remyelination

Correspondence: Qilin Cao, M.D., Kentucky Spinal Cord Injury Research Center, Department of Neurological Surgery, MDR 616, 511 South Floyd Street, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA. Telephone: 502-852-0284; Fax: 502-852-5148; e-mail: q0cao001{at}gwise.louisville.edu

Received April 18, 2007; accepted for publication August 31, 2007.
First published online in STEM CELLS EXPRESS   September 13, 2007.



Promotion of remyelination is an important therapeutic strategy for the treatment of the demyelinating neurological disorders. Adult oligodendrocyte precursor cells (OPCs), which normally reside quiescently in the adult central nervous system (CNS), become activated and proliferative after demyelinating lesions. However, the extent of endogenous remyelination is limited because of the failure of adult OPCs to mature into myelinating oligodendrocytes (OLs) in the demyelinated CNS. Understanding the molecular mechanisms that regulate the differentiation of adult OPCs could lead to new therapeutic strategies to treat these disorders. In this study, we established a stable culture of adult spinal cord OPCs and developed a reliable in vitro protocol to induce their sequential differentiation. Adult OPCs expressed bone morphogenetic protein (BMP) type Ia, Ib, and II receptor subunits, which are required for BMP signal transduction. BMP2 and 4 promoted dose-dependent astrocyte differentiation of adult OPCs with concurrent suppression of OL differentiation. Treatment of OPCs with BMP2 and 4 increased ID4 expression and decreased the expression of olig1 and olig2. Overexpression of olig1 or olig2 blocked the astrocyte differentiation of adult OPCs induced by BMP2 and 4. Furthermore, overexpression of both olig1 and olig2, but not olig1 or olig2 alone, rescued OL differentiation from inhibition by BMP2 and 4. Our results demonstrated that downregulation of olig1 and olig2 is an important mechanism by which BMP2 and 4 inhibit OL differentiation of adult OPCs. These data suggest that blocking BMP signaling combined with olig1/2 overexpression could be a useful therapeutic strategy to enhance endogenous remyelination and facilitate functional recovery in CNS demyelinated disorders.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2007 by AlphaMed Press.